CRIP2
Cysteine-rich protein 2
Also known as: CRIP2_HUMAN, CRP2, ESP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52943
- Gene
- CRIP2
- Ensembl
- ENSG00000182809
- Chromosome
- 14
- Canonical length
- 208 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Plasma membrane
OverviewNCBI Gene
This gene encodes a putative transcription factor with two LIM zinc-binding domains. The encoded protein may participate in the differentiation of smooth muscle tissue. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
Canonical amino-acid sequenceUniProt
208 residues, UniProt reviewed canonical sequence.
>P52943|CRIP2
1 MASKCPKCDK TVYFAEKVSS LGKDWHKFCL KCERCSKTLT PGGHAEHDGK PFCHKPCYAT
61 LFGPKGVNIG GAGSYIYEKP LAEGPQVTGP IEVPAARAEE RKASGPPKGP SRASSVTTFT
121 GEPNTCPRCS KKVYFAEKVT SLGKDWHRPC LRCERCGKTL TPGGHAEHDG QPYCHKPCYG
181 ILFGPKGVNT GAVGSYIYDR DPEGKVQPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRIP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 1,152 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 1,152 nTPM
- blood vessel: 642 nTPM
- cerebral cortex: 258 nTPM
- kidney: 232 nTPM
- amygdala: 231 nTPM
- basal ganglia: 219 nTPM
Single-cell type
- esophageal apical cells: 803 nCPM
- vascular smooth muscle cells: 379 nCPM
- vascular endothelial cells: 365 nCPM
- lymphatic endothelial cells: 337 nCPM
- epididymal principal cells: 267 nCPM
- fallopian secretory cells: 247 nCPM
Immune cell
- T-reg: 116 nTPM
- naive B-cell: 111 nTPM
- memory CD4 T-cell: 81 nTPM
- memory B-cell: 52 nTPM
- naive CD4 T-cell: 18 nTPM
- memory CD8 T-cell: 17 nTPM
Brain region
- hypothalamus: 208 nTPM
- cerebral cortex: 169 nTPM
- hippocampal formation: 167 nTPM
- basal ganglia: 164 nTPM
- thalamus: 154 nTPM
- midbrain: 143 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0
- gnomAD missense Z
- 0
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CRIP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRIP2 as an antibody target. Whether an autoantibody or antibody against CRIP2 could matter depends on whether native CRIP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRIP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CRIP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...